Deepti Behl

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip et al. · Journal of Clinical Oncology · 2019 · 314 citations · Full text

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

Deepti Behl, L.F. Porrata, Svetomir N. Markovic et al. · Leukemia · 2005 · 123 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +11

Outcome of Patients With Small-Vessel Vasculitis Admitted to a Medical ICU

Syed Anjum Khan, Mir Rauf Subla, Deepti Behl et al. · CHEST Journal · 2007 · 67 citations

Rheumatology, Medical Icu, Vasculitis +4

Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas

Deepti Behl, Kay M. Ristow, Svetomir N. Markovic et al. · British Journal of Haematology · 2007 · 53 citations · Full text

Immunology, Pathology, Immune System +20

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study

Herbert L. Duvivier, Michael Rothe, Pam K. Mangat et al. · Journal of Clinical Oncology · 2023 · 34 citations